Quantbot Technologies LP purchased a new stake in shares of Arthur J. Gallagher & Co. (NYSE:AJG – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 12,053 shares of the financial services provider’s stock, valued at approximately $3,391,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. DekaBank Deutsche Girozentrale raised its holdings in shares of Arthur J. Gallagher & Co. by 15.7% during the third quarter. DekaBank Deutsche Girozentrale now owns 109,639 shares of the financial services provider’s stock valued at $30,450,000 after acquiring an additional 14,860 shares in the last quarter. MQS Management LLC bought a new position in Arthur J. Gallagher & Co. in the 3rd quarter worth $749,000. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in shares of Arthur J. Gallagher & Co. by 29.9% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 161,028 shares of the financial services provider’s stock worth $41,756,000 after purchasing an additional 37,070 shares during the period. Swedbank AB bought a new stake in shares of Arthur J. Gallagher & Co. during the 1st quarter valued at about $3,297,000. Finally, Marsico Capital Management LLC raised its stake in Arthur J. Gallagher & Co. by 316.9% in the second quarter. Marsico Capital Management LLC now owns 11,447 shares of the financial services provider’s stock worth $2,968,000 after buying an additional 8,701 shares in the last quarter. Institutional investors own 85.53% of the company’s stock.
Arthur J. Gallagher & Co. Trading Up 0.7 %
Arthur J. Gallagher & Co. stock opened at $315.00 on Thursday. Arthur J. Gallagher & Co. has a 12-month low of $218.63 and a 12-month high of $315.73. The firm has a market capitalization of $69.11 billion, a price-to-earnings ratio of 60.00, a P/E/G ratio of 2.61 and a beta of 0.72. The firm has a 50 day moving average of $289.51 and a 200 day moving average of $278.29. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.64.
Arthur J. Gallagher & Co. Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be given a $0.60 dividend. The ex-dividend date of this dividend is Friday, December 6th. This represents a $2.40 annualized dividend and a dividend yield of 0.76%. Arthur J. Gallagher & Co.’s payout ratio is 45.71%.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the company. Jefferies Financial Group lifted their price objective on Arthur J. Gallagher & Co. from $269.00 to $274.00 and gave the company a “hold” rating in a research report on Wednesday, October 9th. UBS Group upped their price target on Arthur J. Gallagher & Co. from $260.00 to $292.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 31st. Wells Fargo & Company boosted their target price on shares of Arthur J. Gallagher & Co. from $309.00 to $315.00 and gave the company an “overweight” rating in a report on Thursday, October 10th. Truist Financial increased their price target on shares of Arthur J. Gallagher & Co. from $265.00 to $275.00 and gave the stock a “hold” rating in a research note on Friday, September 20th. Finally, Bank of America boosted their price objective on shares of Arthur J. Gallagher & Co. from $271.00 to $293.00 and gave the stock an “underperform” rating in a research note on Thursday, October 10th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $291.64.
View Our Latest Research Report on Arthur J. Gallagher & Co.
Insider Transactions at Arthur J. Gallagher & Co.
In other news, VP Christopher E. Mead sold 2,800 shares of the business’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $287.00, for a total value of $803,600.00. Following the transaction, the vice president now owns 14,674 shares of the company’s stock, valued at approximately $4,211,438. The trade was a 16.02 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Michael Robert Pesch sold 7,100 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $296.20, for a total transaction of $2,103,020.00. Following the transaction, the president now directly owns 33,267 shares of the company’s stock, valued at $9,853,685.40. The trade was a 17.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 23,900 shares of company stock valued at $6,892,280 over the last 90 days. Company insiders own 1.60% of the company’s stock.
Arthur J. Gallagher & Co. Company Profile
Arthur J. Gallagher & Co, together with its subsidiaries, provides insurance and reinsurance brokerage, consulting, and third-party property/casualty claims settlement and administration services to entities and individuals worldwide. It operates in Brokerage and Risk Management segments. The Brokerage segment offers retail and wholesale insurance and reinsurance brokerage services; assists retail brokers and other non-affiliated brokers in the placement of specialized and hard-to-place insurance; and acts as a brokerage wholesaler, managing general agent, and managing general underwriter for distributing specialized insurance coverages to underwriting enterprises.
Further Reading
- Five stocks we like better than Arthur J. Gallagher & Co.
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Most Volatile Stocks, What Investors Need to Know
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Healthcare Dividend Stocks to Buy
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Arthur J. Gallagher & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arthur J. Gallagher & Co. and related companies with MarketBeat.com's FREE daily email newsletter.